AgeX Therapeutics (AGE) Financials

$11.10

$-1.50 (-11.90%)

As on 26-Mar-2024 20:00EDT

Market cap

$28 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

5.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.14	0.03	0.14	1.87	1.73	1.40
Cost of Revenue	0.17	0.01	0.02	0.16	0.24	0.36
Gross Profit	-0.03	0.02	0.13	1.71	1.48	1.03
Operating Expenses	9.93	7.00	8.16	12.38	14.04	12.28
Operating Profit (EBIT)	-9.96	-6.98	-8.04	-10.67	-12.56	-11.25
Other Income	--	--	--	0.04	0.29	3.40
Profit before Tax	-14.81	-10.52	-8.58	-11.13	-12.24	-7.73
Provision for Tax	-0.01	0.15	1.64	-0.15	0.15	3.51
Profit after Tax (Net Income)	-14.80	-10.67	-10.22	-10.98	-12.38	-7.50
Minority Interest	0.06	0.06	0.01	-0.28	0.40	0.78
Consolidated Profit	--	-10.46	-8.68	-10.87	-12.15	-7.50

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	5.47	-17.21	-11.83	-5.12	2.22	7.45
Minority Interest	--	--	--	-0.28	0.40	0.78
Non-Current Liabilities	0.69	10.48	6.06	3.96	1.53	2.12
Current Liabilities	5.91	10.08	8.97	5.36	3.30	2.44
Total Liabilities	11.97	3.24	3.15	3.93	7.44	10.67

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	11.21	0.79	0.92	1.64	3.39	2.82
Current Assets	0.75	2.45	2.23	2.28	4.05	7.85
Total Assets	11.97	3.24	3.15	3.93	7.44	10.67
Total Debt*	4.37	18.12	13.20	6.30	1.96	--
Net Current Assets	-5.16	-7.63	-6.73	-3.07	0.76	5.41

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-7.80	-5.94	-7.86	-7.82	-10.16	-8.00
Cash Flow from Investing Activities	--	--	0.67	-0.02	-0.36	1.33
Cash from Financing Activities	17.50	6.00	7.25	5.96	6.27	6.00
Net Cash Inflow / Outflow	--	--	--	-1.88	-4.26	-0.67

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-13.72	-9.89	-0.27	-0.29	-0.33	-0.21
Cash EPS ($)	-13.60	-9.77	-0.27	-0.25	-0.30	-0.19
Adjusted Book Value ($)	5.07	--	--	--	0.06	0.21
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-7.23	-5.50	-0.21	-0.21	-0.27	-0.22
Free Cash Flow per Share ($)	-7.23	-5.50	-0.21	-0.21	-0.29	-0.28

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-275.51	-935.50	-801.57	-410.01	-213.13	-101.88
ROE (%)	252.12	73.50	120.60	757.49	-256.26	-101.88
ROA (%)	-194.70	-333.82	-288.74	-193.12	-136.74	-73.90
EBIT Margin (%)	-7,014.08	-20,514.71	-5,582.64	-571.25	-726.79	-805.52
Net Margin (%)	-10,424.65	-31,394.12	-7,097.22	-574.06	-612.46	-156.49
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	3.18	-0.76	-0.92	0.08	0.24	-0.01
EBIT Growth (%)	-42.80	13.24	24.66	15.03	-11.69	-10.56
Net Profit Growth (%)	-38.68	-4.44	6.89	11.37	-65.08	-14.01
EPS Growth (%)	-0.39	-35.72	0.07	0.12	-0.57	-20.03
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	-0.03	-0.06	-4.05	-5.22	-5.53	-14.28
Price / Book Value	0.08	-0.03	-3.49	-11.21	30.89	14.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.45	-2.65	-7.23	-7.02	-5.87	-9.38
Close Price ($)	13.54	19.41	38.34	53.46	64.01	105.16
High Price ($)	35.17	48.89	107.62	138.22	179.37	209.26
Low Price ($)	11.61	17.59	18.15	23.42	40.80	39.74
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.80	-1.05	-1.12	-1.23	0.88	--
Short term debt to equity ratio	0.67	-0.44	-0.60	-0.47	0.19	0.01
Current Ratio	0.13	0.24	0.25	0.43	1.23	3.22
Quick Ratio	--	--	--	0.43	--	3.22
Interest Coverage	-2.03	-2.09	-7.33	-21.38	-22.71	-96.94

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	40.14	11.76	17.36	17.45	21.01	9.38
Asset Turnover	0.02	0.01	0.04	0.33	0.19	0.14
Receivable days	78.45	155.77	445.15	67.36	52.21	31.14
Inventory Days	--	--	0.02	0.00	--	--
Payable days	2,613.35	25,356.78	21,136.44	3,175.13	2,047.05	966.81
Cash Conversion Cycle	--	--	-20,691.27	-3,107.77	-1,994.84	-935.67